US-Singapore collaboration to develop next generation allogeneic CAR technologies

US-based startup Elpis Biopharmaceuticals, a clinical-stage cell therapy company developing bispecific armored CAR-...

June 4, 2025 | Wednesday | News
Milestone partnership highlighting Korea’s expanding influence in global biotech innovation

MarkHerz Inc., a South Korea-based biotechnology startup specialising in AAV-based gene therapies targeting cardiovascul...

June 3, 2025 | Tuesday | News
PlasmidFactory: Pioneering Minicircle DNA for Safer and More Efficient Gene Therapies

As the field shifts toward safer and more efficient gene delivery methods, PlasmidFactory’s proprietary technology...

June 1, 2025 | Sunday | News
Japan establishes first next-gen commercial production site for CAR-T cell therapies

Cellares, a pioneer in automated cell therapy manufacturing, in collaboration with Mitsui Fudosan, has announced the est...

May 30, 2025 | Friday | News
Alloy Therapeutics enters Japanese market by establishing operations at Shonan Health Innovation Park

Alloy Therapeutics Inc., a US-based biotechnology ecosystem company, has recently opened its first location in Japa...

May 23, 2025 | Friday | News
US-Saudi Arabi partnership to advance T regulatory cell therapies for unmet diseases

King Faisal Specialist Hospital & Research Centre (KFSHRC) and Cellenkos Inc., a Texas based clinical stage bio...

May 22, 2025 | Thursday | News
Thermo Fisher opens Cell and Gene Therapy Vision Centre in South Korea

Thermo Fisher recently celebrated the opening of its new Cell and Gene Therapy (CGT) Vision Centre in South Korea. The c...

May 17, 2025 | Saturday | News
Japan approves Sarepta's gene therapy to treat Duchenne Muscular Dystrophy

US-based Sarepta Therapeutics, Inc. has announced that the Japanese Ministry of Health, Labour, and Welfare (MHLW) has a...

May 14, 2025 | Wednesday | News
Andelyn Biosciences delivers gene therapy for ultra-rare NEDAMSS disease in record time using AAV Curator® platform

Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Or...

May 12, 2025 | Monday | News
Singapore's Nuevocor raises $45 M to develop mechanobiology-centered therapy for cardiomyopathy

Nuevocor, a Singapore-headquartered IND-stage biotechnology company developing cures for cardiomyopathies driven by aber...

May 6, 2025 | Tuesday | News
RoosterBio announces collaboration with Thermo Fisher to advance cell therapy manufacturing

US-based RoosterBio, Inc., a leading supplier of adult human mesenchymal stem/stromal cells (hMSCs), highly engineered m...

May 2, 2025 | Friday | News
Australia injects $238 M to host national push for next-gen therapy manufacturing

The University of Queensland (UQ) in Australia will host a $238 million industry-led research centre to accelerate indus...

April 28, 2025 | Monday | News
Isolere Bio launches manufacturing-grade IsoTag™ AAV reagent

-Isolere Bio by Donaldson, an innovative bioprocessing technology provider, proudly announces the availability of its ma...

April 25, 2025 | Friday | News
Gilead Sciences to propel healthcare innovation and cell therapy advancement in Abu Dhabi

As part of its commitment to advance healthcare innovation, the Department of Health – Abu Dhabi (DoH), the regula...

April 22, 2025 | Tuesday | News
Korea's DAAN Biotherapeutics and GC Cell join hands to advance CAR-T and CAR-NK cell therapies

South Korea-based DAAN Biotherapeutics, a leading innovative drug development company specialising in T-Cell recept...

April 21, 2025 | Monday | News
Singapore-based BioCell Innovation’s CAR-T process gets funding boost from ScaleReady

BioCell Innovations, a Singapore-based biotechnology startup pioneering next-generation CAR-T therapies, has been awarde...

April 17, 2025 | Thursday | News
Caring Cross and Burjeel Holdings partner to bring CAR-T therapy to MENA

In a major step toward democratising access to advanced healthcare, Burjeel Holdings, a leading super-specialty healthca...

April 11, 2025 | Friday | News
“There are over 650 cell and gene therapy clinical trials underway in APAC region”

What are the company’s major plans in store for 2025, particularly for the APAC region?  The pharmaceutical ...

March 31, 2025 | Monday | Opinion